Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)

BACKGROUND: The French Safety and Appropriateness of Growth Hormone treatments in Europe (SAGhE) cohort has raised concern of increased mortality risk during follow-up into adulthood in certain patients who had received growth hormone (GH) treatment during childhood. The Hypopituitary Control and Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Daojun, Hardin, Dana Sue, Erfurth, Eva Marie, Melmed, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159575/
https://www.ncbi.nlm.nih.gov/pubmed/24122237
http://dx.doi.org/10.1007/s11102-013-0529-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159575/
https://www.ncbi.nlm.nih.gov/pubmed/24122237
http://dx.doi.org/10.1007/s11102-013-0529-6

Ejemplares similares